Karmanos

Karmanos, established in 1943 and headquartered in Detroit, Michigan, is a distinguished provider of comprehensive cancer care and advanced research. Operating within the healthcare industry, the organization is dedicated to offering cutting-edge cancer treatment, pioneering cancer-specific scientific investigation programs, and facilitating access to vital clinical trials. With a significant operational footprint, Karmanos serves its community through a network of 29 locations, supported by a dedicated team of 1,000 to 5,000 employees. This extensive infrastructure enables the delivery of specialized medical services and research initiatives. Meet Karmanos's team to learn more about the professionals driving their mission forward. The company's commitment extends to providing a wide array of cancer-related products and services, including diagnostic capabilities, genetic counseling, and genetic testing, all delivered by an expert team focused on patient outcomes. Karmanos generates substantial revenue, reporting $149.0M, underscoring its significant role in the healthcare sector. Its competitive landscape includes prominent institutions such as Rutgers Cancer Institute of New Jersey, Fox Chase Cancer Center, and the National Cancer Institute, highlighting Karmanos's position among leading cancer care providers. The organization's focus on research and treatment strategy aims to advance cancer care standards and improve patient survival rates.